Abridge押注环境AI于医患对话；3亿美元E轮融资，估值53亿

做的是什么生意

Abridge sells a generative AI platform that ambiently listens to clinician-patient conversations and drafts structured, specialty-specific, billing-ready notes for the EHR.

启动资金：About $27M raised by mid-2022, then $250M Series D (Feb 2025) and $300M Series E (Jun 2025)

起因

Rao, a UPMC cardiologist and former UPMC Enterprises executive, co-founded Abridge in 2018 after realizing he spent more time on notes than with patients. The company first built a patient-facing app that recorded and summarized medical conversations, then launched an enterprise ambient documentation product in 2022 backed by a $12.5M Series A-1 led by Wittington Ventures.

经过

Abridge scaled from about 100 US health systems at its February 2025 Series D (co-led by Elad Gil and IVP) to 150+ by June. Its Contextual Reasoning Engine drafts billable notes at the point of care and pushes into revenue cycle management; the company was named Best in KLAS for Ambient AI and invested in by CVS Health Ventures and NVIDIA.

结果

In June 2025 Abridge closed a $300M Series E led by Andreessen Horowitz with Khosla Ventures, at a reported $5.3B valuation. It said it would support clinicians across more than 50 million medical conversations that year, in 55 specialties and 28 languages, and claimed up to 60-70% burnout reduction with over 90% of clinicians continuing to use it.

可借鉴之处

从创始人亲历的痛苦工作流程开始；一个记录的痛点发展成了整个行业的收入周期层。